rdf:type |
|
lifeskim:mentions |
umls-concept:C0037083,
umls-concept:C0162638,
umls-concept:C0245662,
umls-concept:C0431085,
umls-concept:C0597357,
umls-concept:C1514562,
umls-concept:C1539477,
umls-concept:C1705955,
umls-concept:C1710082,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
1
|
pubmed:dateCreated |
1996-4-23
|
pubmed:databankReference |
|
pubmed:abstractText |
FAS/Apo-1 (CD95) is an apoptosis-signaling cell surface receptor belonging to the TNF receptor family. Tumor cells resistant to Fas-mediated apoptosis have been described, but to date, the mechanisms responsible for this resistance are not well understood. We found that a series of apoptosis-resistant clones from human HUT78 lymphoma cells express a splicing variant coding for a truncated Fas molecule that lacks the intracellular death-signaling domain. The mutation responsible for the FasExo8Del expression was identified as a deletion-insertion in the intron 7/exon 8 region of the Fas gene. Moreover this mutation affects the phenotype in a dominant negative fashion, i.e., even in the presence of the normal receptor.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8598453-Adult,
pubmed-meshheading:8598453-Antigens, CD95,
pubmed-meshheading:8598453-Apoptosis,
pubmed-meshheading:8598453-Base Sequence,
pubmed-meshheading:8598453-Cloning, Molecular,
pubmed-meshheading:8598453-Cytoplasm,
pubmed-meshheading:8598453-Fas Ligand Protein,
pubmed-meshheading:8598453-Humans,
pubmed-meshheading:8598453-Lymphoma, T-Cell,
pubmed-meshheading:8598453-Membrane Glycoproteins,
pubmed-meshheading:8598453-Molecular Sequence Data,
pubmed-meshheading:8598453-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:8598453-Signal Transduction,
pubmed-meshheading:8598453-Tumor Cells, Cultured
|
pubmed:year |
1996
|
pubmed:articleTitle |
Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
|
pubmed:affiliation |
Department of Immunobiology, National Research Council, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|